BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34659082)

  • 21. Paraneoplastic neuropathies.
    Antoine JC; Camdessanché JP
    Curr Opin Neurol; 2017 Oct; 30(5):513-520. PubMed ID: 28682959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.
    Koike H; Tanaka F; Sobue G
    Curr Opin Neurol; 2011 Oct; 24(5):504-10. PubMed ID: 21799410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of anti-SOX1 reactivity in various neurological disorders.
    Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
    J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathies associated with malignancy.
    Amato AA; Collins MP
    Semin Neurol; 1998; 18(1):125-44. PubMed ID: 9562674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study.
    Alsaeed M; Lim CAR; Plecash A; Chen T
    BMC Neurol; 2021 Sep; 21(1):374. PubMed ID: 34579672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic neurological syndromes associated with non-Hodgkin lymphoma: a case series.
    Dinoto A; Cheli M; Catalan M; Olivo S; Scali I; Bertolotti C; Sartori A; Manganotti P
    Neurol Sci; 2022 Mar; 43(3):2077-2079. PubMed ID: 35000013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic neuropathies.
    Graus F; Dalmau J
    Curr Opin Neurol; 2013 Oct; 26(5):489-95. PubMed ID: 23892629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
    Blaes F
    Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
    [No Abstract]   [Full Text] [Related]  

  • 31. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment for paraneoplastic neuropathies.
    Giometto B; Vitaliani R; Lindeck-Pozza E; Grisold W; Vedeler C
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007625. PubMed ID: 23235647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
    Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
    J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment.
    Marsili L; Marcucci S; LaPorta J; Chirra M; Espay AJ; Colosimo C
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
    Berger B; Stich O; Labeit S; Rauer S
    J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
    Honnorat J
    Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
    Li L; Guo Y; Wang J
    Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China.
    Miao S; Liao S; Li H; Niu B; Hu H; Qian Y; Guo H; Cao B
    Int J Neurosci; 2018 Sep; 128(9):821-827. PubMed ID: 29355452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.